Chemical Compound Review:
Mexitil 1-(2,6- dimethylphenoxy)propan-2- amine...
Synonyms:
Ritalmex, mexilitene, Katen, Mexiletine HCL, Prestwick_666, ...
This record was replaced with 4178.
- Muscle cramp in Machado-Joseph disease: altered motor axonal excitability properties and mexiletine treatment. Kanai, K., Kuwabara, S., Arai, K., Sung, J.Y., Ogawara, K., Hattori, T. Brain (2003)
- Mexiletine. Long-term efficacy and side effects in patients with chronic drug-resistant potentially lethal ventricular arrhythmias. Kerin, N.Z., Aragon, E., Marinescu, G., Faitel, K., Frumin, H., Rubenfire, M. Arch. Intern. Med. (1990)
- Contact urticaria induced by mexiletine hydrochloride in a patient receiving iontophoresis. Yamazaki, S., Katayama, I., Kurumaji, Y., Yokozeki, H., Nishioka, K. Br. J. Dermatol. (1994)
- Generalized drug eruption due to mexiletine hydrochloride: topical provocation on previously involved skin. Kikuchi, K., Tsunoda, T., Tagami, H. Contact Derm. (1991)
- Long QTc and torsades de pointes in human immunodeficiency virus disease. Kocheril, A.G., Bokhari, S.A., Batsford, W.P., Sinusas, A.J. Pacing and clinical electrophysiology : PACE. (1997)
- Influence of debrisoquine phenotype and of quinidine on mexiletine disposition in man. Turgeon, J., Fiset, C., Giguère, R., Gilbert, M., Moerike, K., Rouleau, J.R., Kroemer, H.K., Eichelbaum, M., Grech-Bélanger, O., Bélanger, P.M. J. Pharmacol. Exp. Ther. (1991)
- Pharmacokinetics of mexiletine in the elderly. Grech-Bélanger, O., Barbeau, G., Kishka, P., Fiset, C., LeBoeuf, E., Blouin, M. Journal of clinical pharmacology. (1989)
- Stereoselective disposition of mexiletine in man. Grech-Belanger, O., Turgeon, J., Gilbert, M. British journal of clinical pharmacology. (1986)
- Attenuating effect of mexiletine hydrochloride on herpetic pain in mice infected with herpes simplex virus. Asano, K., Sameshima, T., Shirasawa, H., Hisamitsu, T. J. Pharm. Pharmacol. (2003)
- Enantioselective analysis of N-hydroxymexiletine glucuronide in human plasma for pharmacokinetic studies. Lanchote, V.L., Santos, V.J., Cesarino, E.J., Dreossi, S.A., Mere Júnior, Y., Santos, S.R. Chirality. (1999)
- Gas chromatography-electron ionization and chemical ionization mass spectrometric analysis of serum mexiletine concentration after derivatization with 2,2,2-trichloroethyl chloroformate: a novel derivative. Dasgupta, A., Appenzeller, P., Moore, J. Therapeutic drug monitoring. (1998)
- Comparative efficacy and safety of oral mexiletine and quinidine in benign or potentially lethal ventricular arrhythmias. Morganroth, J. Am. J. Cardiol. (1987)
- A case of drug eruption due to simultaneous sensitization with three different kinds of drugs. Nagayama, H., Nakamura, Y., Shinkai, H. J. Dermatol. (1996)
- The dissolution and oral bioavailability of mexiletine capsules modified for clinical trial. A preliminary report. Chan, K., Tse, J., Deeks, P.A., Pilling, M. Methods and findings in experimental and clinical pharmacology. (1983)
- Persistence of the electrophysiologic effects of mexiletine in canine Purkinje fibers alters the response to subsequent hypoxia. Berman, N.D., Ogilvie, R.I., Loukides, J.E. Can. J. Physiol. Pharmacol. (1987)
- Mexiletine hydrochloride in an infant with intractable epilepsy. Kohyama, J., Shimohira, M., Watanabe, S., Fukuda, C., Iwakawa, Y. Brain Dev. (1988)
- Effect of rifampicin treatment on the kinetics of mexiletine. Pentikäinen, P.J., Koivula, I.H., Hiltunen, H.A. Eur. J. Clin. Pharmacol. (1982)
- Acute exanthematous pustular drug eruption induced by mexiletine. Sasaki, K., Yamamoto, T., Kishi, M., Yokozeki, H., Nishioka, K. European journal of dermatology : EJD. (2001)